Khaled Tolba

A phase I dose-escalation trial of 2-deoxy-d-glucose alone or combined with docetaxel in patients with advanced solid tumors

Luis E. Raez, Kyriakos P. Papadopoulos, Alejandro D. Ricart et al. · Cancer Chemotherapy and Pharmacology · 2012 · 509 citations

Oncology, 2-Deoxy-d-glucose Alone, Medicine +8

Promiscuous and allele-specific anchors in HLA-DR-binding peptides

Juergen Hammer, P Valsasnini, Khaled Tolba et al. · Cell · 1993 · 376 citations

Human Leukocyte Antigen, Protein Folding, Peptide Library +4

HSV ICP0 recruits USP7 to modulate TLR-mediated innate response

Sandrine Daubeuf, Divyendu Singh, Yaohong Tan et al. · Blood · 2008 · 141 citations · Full text

Durable Response to Afatinib in Lung Adenocarcinoma Harboring NRG1 Gene Fusions

Nathan D. Gay, Ying Wang, Carol Beadling et al. · Journal of Thoracic Oncology · 2017 · 79 citations

Bronchial Neoplasm, Durable Response, Cancer Genetics +5

Development of herpes simplex virus-1 amplicon–based immunotherapy for chronic lymphocytic leukemia

Khaled Tolba, William J. Bowers, Shannon P. Hilchey et al. · Blood · 2001 · 63 citations · Full text